UFP Technologies Announces Third Quarter Results Meeting Update
UFP Technologies Prepares to Share Third Quarter Financial Results
UFP Technologies, Inc. (NASDAQ: UFPT) is ready to present their financial performance for the third quarter of the fiscal year after the market closes on an upcoming date. This announcement reflects the company's ongoing commitment to transparency and engagement with stakeholders.
Details of the Upcoming Conference Call
The anticipated conference call is scheduled for the following day, providing an opportunity for investors and analysts to gain insight into UFP's latest financial metrics and business direction. The call will take place at 8:30 AM Eastern Time.
Call In Information
Interested participants can easily join the call using these dial-in numbers:
For USA/Canada: Toll-Free: 1-412-206-6478
For International calls: 1-833-890-4010
How to Access the Conference Call
For those unable to join live, UFP Technologies ensures that a replay of the conference call will be accessible. It can be found on the company’s Investor Relations website, where they provide resources for investors seeking updates on UFP Technologies’ performance.
About UFP Technologies, Inc.
UFP Technologies is a leading contract development and manufacturing company specializing in single-use and single-patient medical devices. This organization relies on advanced manufacturing processes and quality assurance standards to support a broad range of medical applications, from minimally invasive surgeries to infection prevention methods.
The Role of UFP in the Medical Supply Chain
As an essential player in the medical device supply chain, UFP collaborates with many top-tier medical device manufacturers. Their specialized products aim to boost operational efficiencies and enhance patient safety across various medical practices, including wound care and orthopedic soft goods.
Contact Information
If you have inquiries regarding UFP Technologies, please reach out to the following:
Investor Contact:
Jeff Elliott,
Three Part Advisors, LLC,
214-966-9014
UFP Technologies Contact:
Ron Lataille, CFO,
978-234-0926,
rlataille@ufpt.com
Frequently Asked Questions
What financial results will UFP Technologies announce?
UFP Technologies will share their financial performance for the third quarter of the current fiscal year.
When will UFP Technologies hold their conference call?
The conference call is scheduled for the day after the financial results are released, at 8:30 AM Eastern Time.
How can I join the conference call?
Participants can call in using the specified numbers provided for USA/Canada and International calls.
Where can I find the replay of the conference call?
A replay of the conference call will be available on the UFP Technologies Investor Relations website after the event.
What products does UFP Technologies specialize in?
UFP Technologies focuses on single-use and single-patient medical devices that are used in various medical applications.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
